Ativan withdrawal. How to safely withdrawal or taper off Ativan Lorazepam. Step by step instructions how to get off Ativan.
If you are new to The Road Back and want more information about how to taper off Ativan before you begin, click Program at the top of this page and you will have free access to How to Get Off Psychoactive Drugs Safely.
If You Are Aleady In Ativan Withdrawal click here
Lorazepam, also sold under the brand name Ativan, is a benzodiazepine medication commonly prescribed for anxiety, seizures, and insomnia. While it can be an effective treatment for these conditions, it also carries a number of potential side effects. In this article, we will explore the various lorazepam side effects in detail.
1. Drowsiness and Sedation – One of the most common side effects of lorazepam is drowsiness or sedation. This effect can be particularly pronounced in the first few days of treatment, and it may take some time for the body to adjust to the medication. Individuals taking lorazepam may experience difficulty with attention and concentration, as well as impaired motor function. Patients should not operate heavy machinery or drive until they know how the medication affects them.
2. Impaired Memory and Cognitive Function Lorazepam can also have an impact on cognitive function, including memory and concentration. This is particularly true in the elderly or in patients taking higher doses of the medication. Some studies have suggested that long-term use of benzodiazepines like lorazepam can increase the risk of developing dementia.
3. Confusion and Disorientation In addition to cognitive impairment, lorazepam can also cause confusion and disorientation. This can be particularly concerning for elderly patients, who may already be experiencing cognitive decline. Patients taking lorazepam should be monitored for signs of confusion, as it may indicate a need to adjust the dosage or discontinue the medication.
4. Respiratory Depression Lorazepam can also have an impact on the respiratory system, potentially causing respiratory depression. This effect is more pronounced in individuals taking higher doses of the medication or those who are already experiencing respiratory issues. Patients should be monitored for signs of respiratory distress, including shortness of breath, shallow breathing, and wheezing.
5. Addiction and Dependence Lorazepam is a habit-forming medication, and long-term use can lead to addiction and dependence. Patients taking the medication for an extended period of time may develop tolerance to the drug, requiring higher doses to achieve the same effect. Abruptly discontinuing the medication can lead to withdrawal symptoms, including seizures and hallucinations.
6. Mood Changes Lorazepam can also cause changes in mood, including depression and anxiety. This effect is particularly pronounced in individuals taking higher doses of the medication or those with a history of mental health issues. Patients should be monitored for signs of depression or anxiety, and the medication should be discontinued if these symptoms become severe.
7. Nausea and Vomiting Lorazepam can cause gastrointestinal distress, including nausea and vomiting. This effect is typically mild and can be managed with over-the-counter medications, but patients should be monitored for signs of dehydration or other complications.
8. Headache and Dizziness Headache and dizziness are common side effects of lorazepam, particularly in the first few days of treatment. These symptoms may be related to the sedative effects of the medication, and they should resolve as the body adjusts to the drug.
9. Muscle Weakness Lorazepam can also cause muscle weakness, particularly in individuals taking higher doses of the medication. Patients should be monitored for signs of weakness or difficulty with motor function, and the medication should be discontinued if these symptoms become severe.
10. Skin Rash Lorazepam can cause skin rash or hives, particularly in individuals with a history of alle
rgies or sensitivity to benzodiazepines. Patients should be monitored for signs of rash or itching, and the medication should be discontinued if these symptoms become severe.11. Hypotension Lorazepam can cause a drop in blood pressure, leading to hypotension. This effect is more pronounced in individuals taking Lorazepam.
12. Sexual Dysfunction Lorazepam can also cause sexual dysfunction, including decreased libido and erectile dysfunction in men. This effect is more pronounced in individuals taking higher doses of the medication or those with a history of sexual dysfunction. Patients should be monitored for signs of sexual dysfunction, and the medication should be discontinued if these symptoms become severe.
13. Liver Damage Lorazepam can cause liver damage in some patients, particularly those taking higher doses of the medication or those with preexisting liver disease. Patients should be monitored for signs of liver damage, including yellowing of the skin or eyes, dark urine, and abdominal pain.
14. Seizures While lorazepam is often used to treat seizures, it can also cause seizures in some patients. This effect is more pronounced in individuals taking higher doses of the medication or those with a history of seizures. Patients should be monitored for signs of seizure activity, including convulsions or loss of consciousness.
15. Allergic Reactions Lorazepam can cause allergic reactions in some patients, particularly those with a history of allergies or sensitivity to benzodiazepines. Patients should be monitored for signs of allergic reaction, including swelling of the face or throat, difficulty breathing, and hives.
16. Withdrawal Symptoms Abruptly discontinuing lorazepam can lead to withdrawal symptoms, including seizures, hallucinations, and insomnia. Patients should be weaned off the medication slowly to avoid these symptoms.
17. Interactions with Other Medications Lorazepam can interact with other medications, particularly those that affect the central nervous system, such as opioids or other benzodiazepines. Patients should inform their healthcare provider of all medications they are taking to avoid potentially dangerous interactions.
18. Tolerance and Dependence As mentioned earlier, long-term use of lorazepam can lead to tolerance and dependence, requiring higher doses of the medication to achieve the same effect. Patients should be monitored for signs of tolerance and dependence, and the medication should be discontinued if these symptoms become severe.
19. Suicidal Thoughts Lorazepam can cause suicidal thoughts or behavior in some patients, particularly those with a history of depression or anxiety. Patients should be monitored for signs of suicidal ideation, and the medication should be discontinued if these symptoms become severe.
20. Pregnancy and Breastfeeding Lorazepam can be harmful to a developing fetus or nursing infant, and should be avoided during pregnancy and breastfeeding unless the potential benefits outweigh the risks. Patients should consult with their healthcare provider before taking lorazepam if they are pregnant or breastfeeding.In conclusion, lorazepam is a commonly prescribed medication that can be effective in treating anxiety, seizures, and insomnia. However, it carries a number of potential side effects, including drowsiness, impaired memory and cognitive function, confusion, respiratory depression, addiction and dependence, mood changes, nausea and vomiting, headache and dizziness, muscle weakness, skin rash, hypotension, sexual dysfunction, liver damage, seizures, allergic reactions, withdrawal symptoms, interactions with other medications, tolerance and dependence, suicidal thoughts, and risks to pregnancy and breastfeeding. Patients taking lorazepam should be closely monitored for these side effects and should consult with their healthcare provider if they experience any concerning symptoms.
21. Falls and Fractures Lorazepam can increase the risk of falls and fractures, particularly in elderly patients or those with a history of falls. Patients taking lorazepam should be monitored for signs of dizziness or impaired balance, and steps should be taken to minimize the risk of falls, such as using assistive devices or modifying the home environment.
22. Respiratory Infections Lorazepam can increase the risk of respiratory infections, particularly in patients with preexisting respiratory issues. Patients taking lorazepam should be monitored for signs of respiratory infections, such as coughing or shortness of breath.
23. Gastrointestinal Bleeding Lorazepam can increase the risk of gastrointestinal bleeding, particularly in patients taking higher doses of the medication or those with a history of gastrointestinal issues. Patients should be monitored for signs of bleeding, including black or tarry stools or vomiting blood.
24. Cardiovascular Effects Lorazepam can have an impact on the cardiovascular system, potentially causing changes in heart rate or blood pressure. Patients with preexisting cardiovascular issues should be closely monitored while taking lorazepam.
25. Vision Changes Lorazepam can cause vision changes, including blurred vision or difficulty focusing. Patients should be monitored for signs of vision changes and should not operate heavy machinery or drive until these symptoms resolve.
26. Weight Changes Lorazepam can cause weight changes, including weight gain or weight loss. Patients should be monitored for changes in weight and should discuss any concerns with their healthcare provider.
27. Interference with Laboratory Tests Lorazepam can interfere with certain laboratory tests, particularly those measuring liver function or drug levels in the blood. Patients should inform their healthcare provider if they are taking lorazepam to ensure that accurate test results are obtained.
28. Impact on Immune Function Lorazepam can have an impact on immune function, potentially increasing the risk of infections or other immune-related issues. Patients with preexisting immune system issues should be closely monitored while taking lorazepam.
29. Impact on Endocrine System Lorazepam can have an impact on the endocrine system, potentially causing changes in hormone levels or function. Patients with preexisting endocrine issues should be closely monitored while taking lorazepam.
30. Impact on Renal Function Lorazepam can have an impact on renal function, potentially causing changes in kidney function or urine output. Patients with preexisting renal issues should be closely monitored while taking lorazepam.In summary, lorazepam is associated with a variety of side effects that can affect multiple organ systems and functions. Patients taking lorazepam should be aware of these potential side effects and should discuss any concerns with their healthcare provider. Regular monitoring and appropriate dosage adjustments can help to minimize the risk of side effects and ensure the safe and effective use of lorazepam.
31. Behavioral Changes Lorazepam can cause behavioral changes, including irritability, agitation, and aggression. These symptoms may be more pronounced in patients taking higher doses of the medication or those with a history of behavioral issues. Patients should be monitored for signs of behavioral changes, and the medication should be discontinued if these symptoms become severe.
32. Anaphylaxis Lorazepam can cause anaphylaxis, a severe and potentially life-threatening allergic reaction. Patients should be monitored for signs of anaphylaxis, including swelling of the face or throat, difficulty breathing, and hives, and should seek immediate medical attention if these symptoms occur.
33. Respiratory Failure In rare cases, lorazepam can cause respiratory failure, a serious condition in which the lungs fail to function properly. Patients should be monitored for signs of respiratory failure, including difficulty breathing, cyanosis (bluish discoloration of the skin), and confusion.
34. Jaundice Lorazepam can cause jaundice, a condition in which the skin and whites of the eyes become yellow due to increased levels of bilirubin in the blood. Patients should be monitored for signs of jaundice, including yellowing of the skin or eyes, dark urine, and pale stools.
35. Stevens-Johnson Syndrome Lorazepam can cause Stevens-Johnson Syndrome, a rare and potentially life-threatening skin condition that can cause blistering and peeling of the skin, as well as mucous membranes such as the mouth and eyes. Patients should be monitored for signs of Stevens-Johnson Syndrome, including rash, blisters, and skin peeling, and should seek immediate medical attention if these symptoms occur.
36. Thrombocytopenia Lorazepam can cause thrombocytopenia, a condition in which there is a low level of platelets in the blood, leading to an increased risk of bleeding. Patients should be monitored for signs of thrombocytopenia, including bruising, bleeding gums, and petechiae (small red or purple spots on the skin).
37. Pancreatitis Lorazepam can cause pancreatitis, a condition in which the pancreas becomes inflamed and swollen, leading to severe abdominal pain, nausea, and vomiting. Patients should be monitored for signs of pancreatitis, and the medication should be discontinued if these symptoms occur.
38. Hypersensitivity Syndrome Lorazepam can cause hypersensitivity syndrome, a rare but potentially life-threatening condition that can cause fever, rash, and multiple organ failure. Patients should be monitored for signs of hypersensitivity syndrome, and the medication should be discontinued if these symptoms occur.
39. Interference with Psychomotor Testing Lorazepam can interfere with psychomotor testing, such as driving tests or other tests of coordination and reaction time. Patients should not participate in these tests until the sedative effects of the medication have worn off.
40. Disinhibition Lorazepam can cause disinhibition, a condition in which patients exhibit impulsive or inappropriate behavior, such as making inappropriate comments or engaging in risky behaviors. Patients should be monitored for signs of disinhibition, and the medication should be discontinued if these symptoms occur.In conclusion, lorazepam can cause a wide range of potential side effects, including respiratory depression, addiction and dependence, mood changes, nausea and vomiting, headache and dizziness, muscle weakness, skin rash, hypotension, sexual dysfunction, liver damage, seizures, allergic reactions, withdrawal symptoms, interactions with other medications, tolerance and dependence, suicidal thoughts, risks to pregnancy and breastfeeding, falls and fractures, respiratory infections, gastrointestinal bleeding, cardiovascular effects, vision changes, weight changes, interference with laboratory tests, impact on immune system, impact on endocrine system, impact on renal function, behavioral changes, anaphylaxis, respiratory failure, jaundice, Stevens-Johnson Syndrome, thrombocytopenia, pancreatitis, hypersensitivity syndrome, interference with psychomotor testing, and disinhibition. Patients taking lorazepam should be closely monitored for these side effects and should discuss any concerns with their healthcare provider. It is important to weigh the potential benefits of the medication against the potential risks and to use lorazepam only under the guidance of a qualified healthcare professional. Regular monitoring and appropriate dosage adjustments can help to minimize the risk of side effects and ensure the safe and effective use of lorazepam.
41. Withdrawal Seizures in Neonates Lorazepam can cause withdrawal seizures in neonates born to mothers who used benzodiazepines during pregnancy. These seizures can be life-threatening and require prompt medical attention.
42. Paradoxical Reactions Lorazepam can cause paradoxical reactions, a rare but potentially serious condition in which patients exhibit the opposite of the desired effect of the medication. For example, instead of feeling sedated, patients may become agitated or hyperactive. Patients should be monitored for signs of paradoxical reactions, and the medication should be discontinued if these symptoms occur.
43. Respiratory Arrest In rare cases, lorazepam can cause respiratory arrest, a serious condition in which breathing stops completely. Patients should be monitored for signs of respiratory distress, and emergency medical attention should be sought if respiratory arrest occurs.
44. Serotonin Syndrome Lorazepam can cause serotonin syndrome, a rare but potentially life-threatening condition in which there is an excessive accumulation of serotonin in the body. Symptoms can include fever, agitation, confusion, tremors, and muscle rigidity. Patients should be monitored for signs of serotonin syndrome, and emergency medical attention should be sought if these symptoms occur.
45. Hyponatremia Lorazepam can cause hyponatremia, a condition in which there is a low level of sodium in the blood. Symptoms can include headache, nausea, vomiting, confusion, and seizures. Patients should be monitored for signs of hyponatremia, and the medication should be discontinued if these symptoms occur.
46. Drug-Induced Psychosis Lorazepam can cause drug-induced psychosis, a condition in which patients experience hallucinations, delusions, and other psychotic symptoms. This effect is more pronounced in individuals taking higher doses of the medication or those with a history of mental health issues. Patients should be monitored for signs of drug-induced psychosis, and the medication should be discontinued if these symptoms become severe.
47. Acute Narrow-Angle Glaucoma Lorazepam can cause acute narrow-angle glaucoma, a serious condition in which there is a sudden increase in pressure inside the eye. Symptoms can include severe eye pain, headache, nausea, and blurred vision. Patients should be monitored for signs of acute narrow-angle glaucoma, and emergency medical attention should be sought if these symptoms occur.
48. Severe Hypotension and Shock Lorazepam can cause severe hypotension and shock, particularly in patients with preexisting cardiovascular issues. Symptoms can include dizziness, lightheadedness, fainting, and rapid heartbeat. Patients should be monitored for signs of severe hypotension and shock, and emergency medical attention should be sought if these symptoms occur.
49. Adverse Effects on Fertility Lorazepam can have adverse effects on fertility in both men and women, including decreased libido, erectile dysfunction, and menstrual irregularities. Patients should discuss any concerns about fertility with their healthcare provider before taking lorazepam.
50. Adverse Effects on Hematopoiesis Lorazepam can have adverse effects on hematopoiesis, the process of blood cell formation. This can result in anemia, leukopenia, or thrombocytopenia, all of which can cause serious health problems. Patients should be monitored for signs of hematopoietic dysfunction, and the medication should be discontinued if these symptoms occur.In conclusion, lorazepam is associated with a wide range of potential side effects, including respiratory depression, addiction and dependence, mood changes, nausea and vomiting, headache and dizziness, muscle weakness, skin rash, hypotension, sexual dysfunction, liver damage, seizures, allergic reactions, withdrawal symptoms, interactions with other medications, tolerance and dependence, suicidal thoughts, risks to pregnancy and breastfeeding, falls and fractures, respiratory infections, gastrointestinal bleeding, cardiovascular effects, vision changes, weight changes, interference with laboratory tests, impact on immune system, impact on endocrine system, impact on renal function, behavioral changes, anaphylaxis, respiratory failure, jaundice, Stevens-Johnson Syndrome, thrombocytopenia, pancreatitis, hypersensitivity syndrome, interference with psychomotor testing, disinhibition, withdrawal seizures in neonates, paradoxical reactions, respiratory arrest, serotonin syndrome, hyponatremia, drug-induced psychosis, acute narrow-angle glaucoma, severe hypotension and shock, adverse effects on fertility, and adverse effects on hematopoiesis. Patients taking lorazepam should be aware of these potential side effects and should discuss any concerns with their healthcare provider. Regular monitoring and appropriate dosage adjustments can help to minimize the risk of side effects and ensure the safe and effective use of lorazepam. Patients should not abruptly stop taking the medication, and should instead work with their healthcare provider to gradually taper the dose to avoid withdrawal symptoms.
51. Increased Risk of Infection Lorazepam can increase the risk of infection, particularly in patients with preexisting immune system issues or those taking higher doses of the medication. Patients taking lorazepam should be monitored for signs of infection, such as fever, chills, or sore throat, and should seek medical attention if these symptoms occur.
52. Cognitive Impairment in the Elderly Lorazepam can cause cognitive impairment in the elderly, particularly in patients taking higher doses of the medication. This can lead to confusion, memory problems, and difficulty with attention and concentration. Elderly patients taking lorazepam should be closely monitored for signs of cognitive impairment.
53. Development of Anterograde Amnesia Lorazepam can cause anterograde amnesia, a condition in which patients have difficulty forming new memories. This effect is more pronounced in patients taking higher doses of the medication or those with a history of memory problems. Patients taking lorazepam should be monitored for signs of anterograde amnesia, and the medication should be discontinued if these symptoms become severe.
54. Psychiatric Symptoms in Children Lorazepam can cause psychiatric symptoms in children, including behavioral changes, mood swings, and aggression. Patients should be monitored for signs of psychiatric symptoms, and the medication should be discontinued if these symptoms become severe.
55. Teratogenicity Lorazepam can be teratogenic, meaning it can cause birth defects or developmental issues in a developing fetus. Patients should avoid taking lorazepam during pregnancy unless the potential benefits outweigh the risks, and should consult with their healthcare provider about alternative treatments.
56. Impact on Sleep Architecture Lorazepam can impact sleep architecture, potentially causing changes in the timing and quality of sleep. Patients taking lorazepam should be monitored for signs of sleep disturbances and should discuss any concerns with their healthcare provider.
57. Gastrointestinal Distress Lorazepam can cause gastrointestinal distress, including nausea, vomiting, and diarrhea. Patients should be monitored for signs of gastrointestinal distress, and the medication should be discontinued if these symptoms become severe.
58. Impact on Driving and Operating Heavy Machinery Lorazepam can cause drowsiness, dizziness, and impaired coordination, making it unsafe to drive or operate heavy machinery while taking the medication. Patients should avoid these activities until the sedative effects of the medication have worn off.
59. Impact on Athletic Performance Lorazepam can impact athletic performance, potentially causing decreased reaction time, impaired coordination, and reduced physical endurance. Athletes taking lorazepam should be aware of these potential side effects and should consult with their healthcare provider before taking the medication.
60. Risk of Overdose Lorazepam can be lethal in overdose, particularly when taken with other central nervous system depressants, such as opioids or alcohol. Patients should be aware of the potential for overdose and should seek immediate medical attention if they experience symptoms of overdose, such as severe drowsiness, confusion, or respiratory depression.In summary, lorazepam is associated with a variety of potential side effects that can affect multiple organ systems and functions, including respiratory depression, addiction and dependence, mood changes, nausea and vomiting, headache and dizziness, muscle weakness, skin rash, hypotension, sexual dysfunction, liver damage, seizures, allergic reactions, withdrawal symptoms, interactions with other medications, tolerance and dependence, suicidal thoughts, risks to pregnancy and breastfeeding, falls and fractures, respiratory infections, gastrointestinal bleeding, cardiovascular effects, vision changes, weight changes, interference with laboratory tests, impact on immune system, impact on endocrine system, impact on renal function, behavioral changes, anaphylaxis, respiratory failure, jaundice, Stevens-Johnson Syndrome, thrombocytopenia, pancreatitis, hypersensitivity syndrome, interference with psychomotor testing, disinhibition, withdrawal seizures in neonates, paradoxical reactions, respiratory arrest, serotonin syndrome, hyponatremia, drug-induced psychosis, acute narrow-angle glaucoma, severe hypotension and shock, adverse effects on fertility, adverse effects on hematopoiesis, increased risk of infection, cognitive impairment in the elderly, development of anterograde amnesia, psychiatric symptoms in children, teratogenicity, impact on sleep architecture, gastrointestinal distress, impact on driving and operating heavy machinery, impact on athletic performance, and risk of overdose. Patients taking lorazepam should be aware of these potential side effects and should discuss any concerns with their healthcare provider. Regular monitoring and appropriate dosage adjustments can help to minimize the risk of side effects and ensure the safe and effective use of lorazepam. Patients should not abruptly stop taking the medication, and should instead work with their healthcare provider to gradually taper the dose to avoid withdrawal symptoms. In addition, patients should avoid drinking alcohol or taking other central nervous system depressants while taking lorazepam, as this can increase the risk of side effects and overdose. It is important to follow all instructions from the healthcare provider and to report any unusual symptoms or side effects to ensure the safe and effective use of lorazepam.
61. Metabolic Acidosis Lorazepam can cause metabolic acidosis, a condition in which there is an accumulation of acid in the body. Symptoms can include rapid breathing, confusion, and fatigue. Patients should be monitored for signs of metabolic acidosis, and the medication should be discontinued if these symptoms occur.
62. Adverse Effects on Bone Health Lorazepam can have adverse effects on bone health, particularly in postmenopausal women. Long-term use of the medication has been associated with an increased risk of osteoporosis and fractures. Patients taking lorazepam for an extended period of time should discuss the potential risks with their healthcare provider and may need to undergo bone density testing.
63. Rebound Anxiety and Insomnia Lorazepam can cause rebound anxiety and insomnia, particularly when the medication is abruptly discontinued. Patients should work with their healthcare provider to gradually taper the dose to avoid these symptoms.
64. Adverse Effects on Hearing Lorazepam can have adverse effects on hearing, potentially causing tinnitus (ringing in the ears) or hearing loss. Patients should be monitored for signs of hearing impairment, and the medication should be discontinued if these symptoms occur.
65. Adverse Effects on Taste and Smell Lorazepam can have adverse effects on taste and smell, potentially causing changes in the perception of taste or smell. Patients should be monitored for signs of changes in taste or smell, and the medication should be discontinued if these symptoms become severe.
66. Adverse Effects on Blood Sugar Control Lorazepam can have adverse effects on blood sugar control, potentially causing hypoglycemia (low blood sugar) in patients with diabetes. Patients with diabetes taking lorazepam should be closely monitored for signs of hypoglycemia, and the medication should be discontinued if these symptoms occur.
67. Adverse Effects on Immune Function Lorazepam can have adverse effects on immune function, potentially increasing the risk of infections or other immune-related disorders. Patients taking lorazepam should be monitored for signs of immune dysfunction, and the medication should be discontinued if these symptoms occur.
68. Adverse Effects on Wound Healing Lorazepam can have adverse effects on wound healing, potentially delaying the healing process and increasing the risk of complications. Patients undergoing surgery or with wounds should avoid taking lorazepam unless absolutely necessary, and should discuss any concerns with their healthcare provider.
69. Adverse Effects on Liver Function Lorazepam can have adverse effects on liver function, potentially causing liver damage or dysfunction. Patients with preexisting liver issues should avoid taking lorazepam, and all patients taking the medication should be monitored for signs of liver dysfunction, such as jaundice or elevated liver enzymes.
70. Adverse Effects on Renal Function Lorazepam can have adverse effects on renal function, potentially causing kidney damage or dysfunction. Patients with preexisting kidney issues should avoid taking lorazepam, and all patients taking the medication should be monitored for signs of renal dysfunction, such as decreased urine output or elevated creatinine levels.In conclusion, lorazepam can cause a wide range of potential side effects that can affect multiple organ systems and functions, including respiratory depression, addiction and dependence, mood changes, nausea and vomiting, headache and dizziness, muscle weakness, skin rash, hypotension, sexual dysfunction, liver damage, seizures, allergic reactions, withdrawal symptoms, interactions with other medications, tolerance and dependence, suicidal thoughts, risks to pregnancy and breastfeeding, falls and fractures, respiratory infections, gastrointestinal bleeding, cardiovascular effects, vision changes, weight changes, interference with laboratory tests, impact on immune system, impact on endocrine system, impact on renal function, behavioral changes, anaphylaxis, respiratory failure, jaundice, paradoxical reactions, respiratory arrest, serotonin syndrome, hyponatremia, drug-induced psychosis, acute narrow-angle glaucoma, severe hypotension and shock, adverse effects on fertility, adverse effects on hematopoiesis, increased risk of infection, cognitive impairment in the elderly, development of anterograde amnesia, psychiatric symptoms in children, teratogenicity, impact on sleep architecture, gastrointestinal distress, impact on driving and operating heavy machinery, impact on athletic performance, risk of overdose, metabolic acidosis, adverse effects on bone health, rebound anxiety and insomnia, adverse effects on hearing, adverse effects on taste and smell, adverse effects on blood sugar control, adverse effects on immune function, adverse effects on wound healing, adverse effects on liver function, and adverse effects on renal function. Patients taking lorazepam should be aware of these potential side effects and should discuss any concerns with their healthcare provider. Regular monitoring and appropriate dosage adjustments can help to minimize the risk of side effects and ensure the safe and effective use of lorazepam. Patients should not abruptly stop taking the medication, and should instead work with their healthcare provider to gradually taper the dose to avoid withdrawal symptoms. In addition, patients should avoid drinking alcohol or taking other central nervous system depressants while taking lorazepam, as this can increase the risk of side effects and overdose. It is important to follow all instructions from the healthcare provider and to report any unusual symptoms or side effects to ensure the safe and effective use of lorazepam.
71. Adverse Effects on Sexual Function Lorazepam can have adverse effects on sexual function, potentially causing decreased libido, erectile dysfunction, or difficulty achieving orgasm. Patients should be monitored for signs of sexual dysfunction, and the medication should be discontinued if these symptoms become severe.
72. Adverse Effects on Mood and Behavior Lorazepam can have adverse effects on mood and behavior, potentially causing irritability, aggression, or other changes in behavior. Patients should be monitored for signs of mood or behavior changes, and the medication should be discontinued if these symptoms become severe.
73. Development of Dependence and Withdrawal Symptoms Lorazepam can cause physical and psychological dependence, particularly when taken at high doses or for an extended period of time. Patients who stop taking lorazepam may experience withdrawal symptoms, including anxiety, insomnia, seizures, and hallucinations. Patients should work with their healthcare provider to gradually taper the dose of lorazepam to avoid withdrawal symptoms.
74. Paradoxical Reactions in Pediatric Patients Lorazepam can cause paradoxical reactions in pediatric patients, particularly those with attention deficit hyperactivity disorder (ADHD) or developmental disorders. Paradoxical reactions can include hyperactivity, agitation, and aggressive behavior. Pediatric patients taking lorazepam should be closely monitored for signs of paradoxical reactions, and the medication should be discontinued if these symptoms occur.
75. Adverse Effects on Memory and Learning Lorazepam can have adverse effects on memory and learning, potentially causing difficulties with memory recall and retention. Patients taking lorazepam should be monitored for signs of memory or learning difficulties, and the medication should be discontinued if these symptoms become severe.
76. Adverse Effects on Endocrine Function Lorazepam can have adverse effects on endocrine function, potentially causing changes in hormone levels or function. Patients taking lorazepam should be monitored for signs of endocrine dysfunction, and the medication should be discontinued if these symptoms become severe.
77. Adverse Effects on Reproductive Function Lorazepam can have adverse effects on reproductive function, potentially causing changes in fertility or menstrual cycles. Patients taking lorazepam should be monitored for signs of reproductive dysfunction, and the medication should be discontinued if these symptoms become severe.
78. Adverse Effects on Cognitive Function in Neonates Lorazepam can have adverse effects on cognitive function in neonates, particularly when used for sedation or as a treatment for seizures. Neonates taking lorazepam should be closely monitored for signs of cognitive dysfunction, and the medication should be discontinued if these symptoms occur.
79. Adverse Effects on Pulmonary Function Lorazepam can have adverse effects on pulmonary function, potentially causing respiratory depression or other breathing problems. Patients taking lorazepam should be monitored for signs of respiratory distress, and the medication should be discontinued if these symptoms become severe.
80. Adverse Effects on Vision and Eye Health Lorazepam can have adverse effects on vision and eye health, potentially causing blurred vision, double vision, or other visual disturbances. Patients taking lorazepam should be monitored for signs of visual disturbances, and the medication should be discontinued if these symptoms become severe. In summary, lorazepam can cause a wide range of potential side effects that can affect multiple organ systems and functions, including respiratory depression, addiction and dependence, mood changes, nausea and vomiting, headache and dizziness, muscle weakness, skin rash, hypotension, sexual dysfunction, liver damage, seizures, allergic reactions, withdrawal symptoms, interactions with other medications, tolerance and dependence, suicidal thoughts, risks to pregnancy and breastfeeding, falls and fractures, respiratory infections, gastrointestinal bleeding, cardiovascular effects, vision changes, weight changes, interference with laboratory tests, impact on immune system, impact on endocrine system, impact on renal function, behavioral changes, anaphylaxis, respiratory failure, jaundice, Stevens-Johnson Syndrome, thrombocytopenia, pancreatitis, hypersensitivity syndrome, interference with psychomotor testing, disinhibition, withdrawal seizures in neonates, paradoxical reactions, respiratory arrest, serotonin syndrome, hyponatremia, drug-induced psychosis, acute narrow-angle glaucoma, severe hypotension and shock, adverse effects on fertility, adverse effects on hematopoiesis, increased risk of infection, cognitive impairment in the elderly, development of anterograde amnesia, psychiatric symptoms in children, teratogenicity, impact on sleep architecture, gastrointestinal distress, impact on driving and operating heavy machinery, impact on athletic performance, risk of overdose, metabolic acidosis, adverse effects on bone health, rebound anxiety and insomnia, adverse effects on hearing, adverse effects on taste and smell, adverse effects on blood sugar control, adverse effects on immune function, adverse effects on wound healing, adverse effects on liver function, adverse effects on renal function, adverse effects on sexual function, adverse effects on mood and behavior, development of dependence and withdrawal symptoms, paradoxical reactions in pediatric patients, adverse effects on memory and learning, adverse effects on endocrine function, adverse effects on reproductive function, adverse effects on cognitive function in neonates, adverse effects on pulmonary function, and adverse effects on vision and eye health. Patients taking lorazepam should be aware of these potential side effects and should discuss any concerns with their healthcare provider. Regular monitoring and appropriate dosage adjustments can help to minimize the risk of side effects and ensure the safe and effective use of lorazepam. Patients should not abruptly stop taking the medication, and should instead work with their healthcare provider to gradually taper the dose to avoid withdrawal symptoms. In addition, patients should avoid drinking alcohol or taking other central nervous system depressants while taking lorazepam, as this can increase the risk of side effects and overdose. It is important to follow all instructions from the healthcare provider and to report any unusual symptoms or side effects to ensure the safe and effective use of lorazepam.
1. Phenobarbital and symptom-triggered lorazepam versus lorazepam alone for severe alcohol withdrawal in the intensive care unit
A symptom-triggered lorazepam regimen is the standard for treating alcohol withdrawal syndrome (AWS) in an inpatient setting. However, in severe AWS, lorazepam requirements can reach significant amounts and lead to risk of delirium and propylene glycol toxicity. Phenobarbital has been shown to be an effective adjunctive therapy for AWS, reducing benzodiazepine use, in the emergency department. The purpose of this study is to determine the efficacy and safety of phenobarbital in adjunct to symptom-triggered lorazepam for severe AWS vs. lorazepam alone in the intensive care unit (ICU). A retrospective cohort was conducted at Cleveland Clinic hospitals from 2013 to 2018 of ICU patients with AWS receiving either phenobarbital adjunct to symptom-triggered lorazepam or lorazepam alone. The primary outcome was the total duration of treatment. Secondary outcomes include ICU length of stay, change in CIWA-Ar score at 24 h, incidence of hypotension, mechanical ventilation, and serum osmolar gap. A total of 72 ICU patients were included with 36 patients in each arm. The median duration of treatment in the phenobarbital adjunct arm was 2.7 days (IQR = 1.7-6.4), compared to 3.1 days (IQR = 1.6-4.8) in the lorazepam arm (p = 0.578). The median ICU length of stay was similar between both arms [4.1 days (IQR = 2.4-8.4) vs. 4.5 days (IQR = 2.8-6.1), p = 0.727]. The average change in CIWA-Ar from baseline at 24 h was significantly lower for those who received phenobarbital (1.8 ± 9.0 vs. 6.5 ± 8.5, p = 0.028). Three patients in the phenobarbital-adjunct group received mechanical ventilation after starting phenobarbital treatment. There were no new incidences of hypotension or increased osmol gap >10 mmol/L after starting treatment in both groups. In conclusion, phenobarbital is an effective adjunct to symptom-triggered lorazepam in severe alcohol withdrawal in the ICU with no significant difference in adverse events.
2. Phenobarbital Versus Lorazepam for Management of Alcohol Withdrawal Syndrome: A Retrospective Cohort Study
Introduction Annually, 500,000 episodes of alcohol withdrawal syndrome (AWS) are severe enough to require clinical attention. A symptom-triggered lorazepam regimen remains the standard of care for the management of hospitalized AWS patients. However, phenobarbital has also been shown to be an effective adjunctive therapy for severe AWS, reducing benzodiazepine use in the emergency department (ED) and the intensive care unit (ICU). The purpose of this study is to compare hospital length of stay (LOS) for AWS patients using phenobarbital-based versus lorazepam-based treatment protocols as monotherapy for management of AWS on general medical units. Methods This is a retrospective cohort study over a two-year period (March, 2016 to March, 2018), conducted at three hospitals within the St. Joseph Mercy Health System. We included 606 patients with a primary diagnosis of AWS or alcohol intoxication who met our inclusion criteria (543 in the lorazepam cohort and 63 in the phenobarbital cohort). Adjusted comparisons were done using propensity scoring methods. Hospital LOS was set as the primary outcome. Secondary outcomes included all-cause 30-day readmission, alcohol-related 30-day readmission, 30-day ED visits after discharge, and need for ICU transfer during hospital stay. Results Patients who received phenobarbital had a statistically significant shorter hospital LOS as compared to patients who received lorazepam (2.8 versus 3.6 days, P < 0.001). Furthermore, the phenobarbital treatment group had statistically significant lower rates of all-cause 30-day readmission (11.11% versus 14.18%, P = 0.020) and 30-day ED visits after discharge (11.11% versus 18.6%, P = 0.015). No statistical significance was detected for alcohol-related 30-day readmission and the need for ICU transfer between the treatment groups. Conclusion This study suggests that phenobarbital may be a reasonable alternative to lorazepam in the management of AWS patients admitted to general medical units. Larger scale, well-executed, and adequately powered prospective studies and randomized controlled trials are needed to corroborate these findings.
3. Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Studies on psychotropic medications decrease, discontinuation, or switch have uncovered withdrawal syndromes. The present overview aimed at analyzing the literature to illustrate withdrawal after decrease, discontinuation, or switch of psychotropic medications based on the drug class (i.e., benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonists, antidepressants, ketamine, antipsychotics, lithium, mood stabilizers) according to the diagnostic criteria of Chouinard and Chouinard [Psychother Psychosom. 2015;84(2):63-71], which encompass new withdrawal symptoms, rebound symptoms, and persistent post-withdrawal disorders. All these drugs may induce withdrawal syndromes and rebound upon discontinuation, even with slow tapering. However, only selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, and antipsychotics were consistently also associated with persistent post-withdrawal disorders and potential high severity of symptoms, including alterations of clinical course, whereas the distress associated with benzodiazepines discontinuation appears to be short-lived. As a result, the common belief that benzodiazepines should be substituted by medications that cause less dependence such as antidepressants and antipsychotics runs counter the available literature. Ketamine, and probably its derivatives, may be classified as at high risk for dependence and addiction. Because of the lag phase that has taken place between the introduction of a drug into the market and the description of withdrawal symptoms, caution is needed with the use of newer antidepressants and antipsychotics. Within medication classes, alprazolam, lorazepam, triazolam, paroxetine, venlafaxine, fluphenazine, perphenazine, clozapine, and quetiapine are more likely to induce withdrawal. The likelihood of withdrawal manifestations that may be severe and persistent should thus be taken into account in clinical practice and also in children and adolescents.
4. Lorazepam
Lorazepam is FDA-approved for short-term (4 months) relief of anxiety symptoms related to anxiety disorders, anxiety-associated insomnia, anesthesia premedication in adults to relieve anxiety or to produce sedation/amnesia, and treatment of status epilepticus. Off-label (non-FDA-approved) uses for lorazepam include rapid tranquilization of the agitated patient, alcohol withdrawal delirium, alcohol withdrawal syndrome, insomnia, panic disorder, delirium, chemotherapy-associated anticipatory nausea, and vomiting (adjunct or breakthrough), as well as psychogenic catatonia. This activity covers lorazepam, including mechanism of action, pharmacology, adverse event profiles, eligible patient populations, and monitoring. It also highlights the interprofessional team’s role in managing lorazepam therapy.
5. Benzodiazepines vs barbiturates for alcohol withdrawal: Analysis of 3 different treatment protocols
Introduction: Alcohol withdrawal treatment varies widely. Benzodiazepines are the standard of care, with rapid onset and long durations of action. Recent drug shortages involving IV benzodiazepines have required incorporation of alternative agents into treatment protocols. Phenobarbital has similar pharmacokinetics to select benzodiazepines frequently used for alcohol withdrawal. The objective of this study is to describe the effectiveness and safety of our institutional protocols during three time periods utilizing benzodiazepines and barbiturates for the acute treatment of alcohol withdrawal in the emergency department.
Methods: Adult patients presenting to the ED for acute alcohol withdrawal from April 1st, 2016 to January 31st, 2018 were reviewed. Patients who received at least one dose of treatment were included. Treatments were based on availability of medication and given protocol at time of presentation. The primary outcome was the rate of ICU admission.
Results: 300 patient encounters were included. Overall baseline characteristics were equal across groups, except for age. There was no difference in rate of ICU admission from the ED between groups (D:8, L&P:11, P:13 patients, p = 0.99). Rate of mechanical ventilation was no different across all groups (D:1, L&P:3, P:3 patients, p = 0.55).
Conclusion: During benzodiazepine shortages, phenobarbital is a safe and effective treatment alternative for alcohol withdrawal. Incorporating phenobarbital into a benzodiazepine based protocol or as sole agent led to similar rates of ICU admission, length of stay, and need for mechanical ventilation in patients treated for alcohol withdrawal in the emergency department.
6. Lorazepam-efficacy, side effects, and rebound phenomena
Lorazepam, 4 mg, was evaluated in an 18-night sleep-laboratory study involving five insomniac subjects. Hypnotic effectiveness and effects on sleep stages and related parameters were assessed. Placebo was given on baseline nights 1 to 4, lorazepam on nights 5 to 11, and placebo was given again on withdrawal nights 12 to 18. Subjective and objective data clearly demonstrated that lorazepam was effective for both inducing and maintaining sleep. Sleep latency was reduced from a baseline value of 34.6 min to 17.9 min (P less than 0.01) and total wake time was reduced from 75.9 to 38.5 min (P less than 0.01). On the third and fifth nights of drug withdrawal total wake time rose above baseline levels (termed rebound insomnia) and sleep latency increased by 77% and 60% over baseline (P less than 0.01). Subjective estimates of daytime anxiety also increased above baseline (rebound anxiety) during the withdrawal period. All subjects experienced severe hangover and varying degrees of impaired functioning during the first 3 days on drug. Three subjects also experienced anterograde amnesia during the day after the first drug night. These side effects diminished in intensity over the course of the study. Our results suggest that while 4 mg lorazepam may be effective in inducing and maintaining sleep, this dose induces clinically significant side effects that are followed by consistent rebound phenomena after withdrawal.
7. Atypical behavioural effects of lorazepam: clues to the design of novel therapies?
Aside from their pharmacokinetic properties, e.g. their speed of action and the duration of residual effects, benzodiazepines are still considered as equivalent in terms of their effects on cognition. Here we review evidence suggesting that certain benzodiazepines, especially lorazepam, differ in a number of respects, in particular with respect to their effects on cognition. We focus this review on memory, attention and visual perception, where impairments may be brought about by only a subset of benzodiazepines in spite of their administration at doses inducing similar sedative effects. This precludes an explanation in terms of sedation. Differences in the effects of benzodiazepines have also been found in electrophysiological and animal behavioural studies. These studies are important for therapeutic approaches for two reasons: first, effects of benzodiazepine prescription on cognitive functions will differ according to the benzodiazepine, contrary to what is usually believed. Less straightforwardly are the possible therapeutic implications of specific effects on cognition following treatment with lorazepam. Indeed, the specific effects this drug has on cognition may reveal not only side-effects but also effects of potential therapeutic value. Current research concentrates on a fine scale analysis of the effects of GABA on different sub-types of GABA(A) receptors. We suggest that from looking at what makes lorazepam different in a behavioural sense from other benzodiazepines we may be in a position to design innovative treatments for major aspects of complex disorders, including schizophrenia.
8. Acute lorazepam effects on neurocognitive performance
A double-blind, placebo-controlled, crossover design was employed to determine whether acute lorazepam (2 mg orally) cognitive side effects would emerge in a differential age-dependent fashion in 15 young (mean age=22 years) and 12 older (mean age=64 years) subjects. Acute use of lorazepam is frequently the initial treatment choice for convulsive status epilepticus or repetitive seizure clusters. Cognitive assessment was performed during drug and placebo conditions using a computerized battery of cognitive tests. With the exception of performance on the reasoning composite score, significant drug effects were present on all primary cognitive domain measures. However, the only significant drug-by-age interaction effect was seen for dual-task performance. The relationship between test performance and plasma lorazepam concentrations was generally modest and non-significant, suggesting that individual differences in pharmacokinetics are not a major factor contributing to the emergence of cognitive side effects. Despite robust lorazepam effects on multiple measures of neurocognitive function, differential age effects are largely restricted to dual-task performance. These results indicate that with the exception of dual-task performance, older individuals in the age range of this study do not appear to be at increased risk for the emergence of cognitive side effects following a single 2-mg dose of lorazepam.
9. Efficacy and side effects of lorazepam, oxazepam, and temazepam as sleeping aids in psychogeriatric inpatients
The efficacy and side effects of 2 mg of lorazepam, 30 mg of oxazepam, and 20 mg of temazepam as sleeping aids were investigated in 20 psychogeriatric inpatients. The drugs were administered in a random order, double-blind, for 7 night each. All of these short half-life benzodiazepines proved efficacious in maintaining sleep. None of them reduced initial sleep latency. Oxazepam and to a lesser degree temazepam induced withdrawal insomnia during the first night after the treatments. The withdrawal of lorazepam induced a delayed but prolonged insomnia in 3 patients. Both lorazepam and oxazepam had muscle relaxant side effects after awakening.
10. Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors
Background: The benzodiazepine lorazepam is widely utilized in the treatment of elderly individuals with anxiety disorders and related conditions. Negative effects of acute lorazepam administration on cognitive performance, especially memory, have been reported in both previously untreated elderly and in individuals who have received short term (up to three weeks) treatment with therapeutic doses. However, it remains unclear if these adverse cognitive effects also persist after long-term use, which is frequently found in clinical practice.
Methods: Cognitively intact elderly individuals (n=37) on long-term (at least three months) daily treatment with lorazepam were studied using a double-blind placebo-controlled cross-over study design. Subjects were administered their highest daily unit dose of lorazepam (0.25-3.00 mg) or placebo on different days, approximately 1 week apart in a random order, and were assessed on memory, psychomotor speed, and subjective mood states.
Results: Subjects had significantly poorer recall and slowed psychomotor performance following acute lorazepam administration. There were no significant effects on self-ratings of mood, sedation, or anxiety in the whole group, but secondary analyses suggested a differential response in subjects with Generalized Anxiety Disorder.
Conclusions: The reduced recall and psychomotor slowing that we observed, along with an absence of significant therapeutic benefits, following acute lorazepam administration in elderly long-term users reinforces the importance of cognitive toxicity as a clinical factor in benzodiazepine use, especially in this population.
Keywords: Aging; Benzodiazepines; Cognitive toxicity; Lorazepam; Memory loss; Psychomotor slowing.